Skip to main content

Umbilical Vein Grafts for Lower Limb Revascularization

  • Chapter
  • First Online:
Regenerative Medicine Using Pregnancy-Specific Biological Substances

Abstract

The autologous saphenous vein is the standard against which the performance of all other vascular grafts is measured. However, even autologous saphenous vein is far from ideal. It may be absent or diseased or too small or too short, and time is required for procurement and preparation. Finally, after implantation as an arterial conduit, it may undergo various forms of biodegradation. Therefore, an alternative vascular conduit is still needed when revascularization is mandatory but the saphenous vein is absent or inadequate, for any reason.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dardik H, Dardik I. The fate of human umbilical cord vessels used as interposition arterial grafts in the baboon. Surg Gynecol Obstet. 1975;140:567.

    CAS  PubMed  Google Scholar 

  2. Anzola J, Palmer TH, Welch S. Long femoral and iliofemoral grafts. Surg Forum. 1951;2:223.

    Google Scholar 

  3. Nabseth DC, Wilson JT, Tan B, et al. Fetal arterial heterografts. Arch Surg. 1960;81:929.

    CAS  PubMed  Google Scholar 

  4. Yong NK, Eiseman B. The experimental use of heterologous umbilical vein grafts as aortic substitutes. Singapore Med J. 1962;3:52.

    CAS  PubMed  Google Scholar 

  5. Carpentier A, Blondeau P, Laurens P. Replacement des valvules mitales et triscuspides pare des heterogrefes. Ann Chir Thorac Cardiovasc. 1968;7:33.

    CAS  PubMed  Google Scholar 

  6. Rosenberg N, Martinez A, Sawyer PN, et al. Tanned collagen arterial prosthesis of bovine carotid origin in man: Preliminary studies of enzyme-treated heterografts. Ann Surg. 1966;164:247.

    Article  CAS  PubMed  Google Scholar 

  7. Dardik H, Dardik I. Successsful arterial substitution with modified human umbilical vein. Ann Surg. 1976;183:252.

    Article  CAS  PubMed  Google Scholar 

  8. Dardik H, Ibrahim IM, Dardik I. Modified and unmodified umbilical vein allografts and xenografts employed as arterial substitutes: a morphologic assessment. Surg Forum. 1976;26:286.

    Google Scholar 

  9. Perloff LJ, Christie BA, Ketharanathan V, et al. A new replacement for small vessels. Surgery. 1981;89:31.

    CAS  PubMed  Google Scholar 

  10. Baier RE, Abbott WM. Comparative biophysical properties of the flow surfaces of contemporary vascular grafts. In: Dardik H, ed. Grafts Materials in Vascular Surgery. Miami, FL: Symposia Specialists; 1978:79.

    Google Scholar 

  11. Baier RE, Akers CH, Perlmutter S, et al. Processed human umbilical cord veins for vascular reconstructive surgery. Trans Am Soc Artif Intern Organs. 1976;22:514.

    CAS  PubMed  Google Scholar 

  12. Dardik H. The use of an adjunctive arteriovenous fistula in distal extremity bypass grafts with outflow obstruction. In: Kempczinski RF, ed. The Ischemic Leg. Chicago: Year Book Medical Publishers; 1985.

    Google Scholar 

  13. Dardik H, Silvestri R, Alasio T, et al. Improved method to create the common ostium variant of the distal arteriovenous fistula for enhancing crural prosthetic graft patency. J Vasc Surg. 1996;24:240.

    Article  CAS  PubMed  Google Scholar 

  14. Rutherford R, Jones DN, Bergentz SE, et al. The efficacy of Dextran 40 in preventing early postoperative thrombosis following difficult lower extremity bypass. J Vasc Surg. 1984;1:767.

    Google Scholar 

  15. Aalders GJ, Van Vroonhoven JMV, Lobach JHC, et al. PTFE versus human umbilical vein in clinical trial. J Cardiovasc Surg. 1988;29:186.

    CAS  Google Scholar 

  16. Eickhoff JH, Broome A, Ericsson BF, et al. Four years’ results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J Vasc Surg. 1987;6:506.

    Article  CAS  PubMed  Google Scholar 

  17. McCollum C, Kenchington G, Alexander C, et al. PTFE or HUV for femoro-popliteal bypass: A multi-centre trial. Eur J Vasc Surg. 1990;5:435.

    Article  Google Scholar 

  18. Dardik H, Miller N, Dardik A, et al. A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vasc Surg. 1988;7:336.

    Article  CAS  PubMed  Google Scholar 

  19. Dardik H. The second decade of experience with the umbilical vein graft for lower-limb revascularization. Cardiovasc Surg. 1995;3:265.

    Article  CAS  PubMed  Google Scholar 

  20. Dardik H. The threatened limb. Sci Med. 1997;4:44.

    Google Scholar 

  21. Dardik H, Ibrahim IM, Dardik I. The role of the peroneal artery for limb salvage. Ann Surg. 1979;189:189.

    Google Scholar 

  22. Dardik H. Technical aspects of umbilical bypass to the tibial vessels. J Vasc Surg. 1984;1:916.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alan Dardik .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer London

About this chapter

Cite this chapter

Dardik, A., Dardik, H. (2011). Umbilical Vein Grafts for Lower Limb Revascularization. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-718-9_19

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-717-2

  • Online ISBN: 978-1-84882-718-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics